Related Experiment Video
Updated: Jul 15, 2025

Basophil Activation Test for Investigation of IgE-Mediated Mechanisms in Drug Hypersensitivity
Published on: September 16, 2011
Practical Approach to Hypersensitivity to Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Children
Daniela Podlecka1, Anna Socha-Banasiak2, Joanna Jerzynska1
1Department of Pediatrics and Allergy, Copernicus Memorial Hospital in Lodz, Medical University of Lodz, 90-419 Lodz, Poland.
Insights
Non-steroidal anti-inflammatory drug (NSAID) hypersensitivity affects 30.1% of children presenting with adverse reactions. Ibuprofen-induced hypersensitivity commonly causes urticaria and angioedema, with vitamin D deficiency as a risk factor.
Area of Science:
- Pediatric Allergy and Immunology
- Pharmacovigilance
- Clinical Diagnostics
Background:
- Assessing real-world prevalence of drug hypersensitivity to NSAIDs in children.
- Characterizing patient profiles and clinical presentations post-adverse event.
- Utilizing drug challenge tests for verification.
Purpose of the Study:
- To determine the prevalence of NSAID hypersensitivity in children.
- To identify patient demographics and clinical signs of NSAID hypersensitivity.
- To explore risk factors associated with NSAID hypersensitivity.
Main Methods:
- Inclusion of 56 children (aged 4-18) with suspected adverse reactions to NSAIDs.
- Performance of skin prick tests and drug provocation tests.
- Diagnostic workup for persistent urticaria.
Main Results:
- NSAID hypersensitivity confirmed in 30.1% of patients (17/56).
- Angioedema and urticaria were the most frequent manifestations (84.9%).
- Ibuprofen was the most common NSAID involved; vitamin D deficiency was a significant risk factor (OR=5.76).
Conclusions:
- NSAID hypersensitivity presents diagnostic challenges in pediatric allergy.
- Acute urticaria and angioedema are key indicators of ibuprofen hypersensitivity in children.
- Vitamin D levels and viral infections warrant further investigation as potential cofactors.
Background:
We aimed to assess the real-life prevalence, patient profile, and clinical presentation of drug hypersensitivity to NSAIDs in children after an incidence of an adverse event during treatment, verified by a drug challenge test.
Methods:
We included 56 children, aged 4-18 years, referred to our allergy clinic due to the incidence of adverse reaction during treatment. Skin prick tests and a drug provocation test were performed in all patients. Diagnostics for persistent urticaria were performed.
Results:
In 56 patients suspected of drug allergy, we proved NSAID hypersensitivity in 17 patients (30.1%). In 84.9% (n = 47) of patients, the clinical manifestations of hypersensitivity revealed angioedema and urticaria. The most common culprit drug among NSAIDs in children was ibuprofen. Thirty-one (55.4%) reactions were immediate, and 25 (44.6%) were delayed or late. Previous history of allergy was a risk factor for NSAID hypersensitivity (p = 0.001). Vitamin D deficiency in the blood serum was a risk factor for NASID hypersensitivity (OR = 5.76 (95% Cl: 1.42-23.41)).
Conclusions:
Hypersensitivity to NSAIDs is a difficult diagnostic problem in pediatric allergy. The most common manifestation of hypersensitivity to ibuprofen in children is acute urticaria and angioedema. Two important problems in the differential diagnosis are cofactors such as vitamin D levels and viral infections, which require further research.
Related Concept Videos
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Factors Affecting Drug Response: Overview
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Therapeutic Index
Allergic Reactions

